Catherine Frenette

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma

Amit G. Singal, Nicole E. Rich, Neil Mehta et al. · Gastroenterology · 2019 · 190 citations · Full text

Medicine, Infectious Diseases, Pharmacology +11

Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study

Neil Mehta, Jennifer Guy, Catherine Frenette et al. · Clinical Gastroenterology and Hepatology · 2017 · 187 citations · Full text

Medicine, Oncology, Surgery +16

Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study

Amit G. Singal, Nicole E. Rich, Neil Mehta et al. · Gastroenterology · 2019 · 162 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Current management of hepatocellular carcinoma.

Ana Maria Crissien, Catherine Frenette · PubMed · 2014 · 151 citations

Medicine, Oncology, Diagnostic Imaging +16